THE GLOBAL IVD RAW MATERIALS MARKET SIZE WAS VALUED AT USD 24.34 BILLION IN 2021 AND IS EXPECTED TO REACH USD 34.25 BILLION BY 2027, GROWINF AT A CAGR OF 5.86% DURING THE FORECAST PERIOD

The Global In Vitro Diagnostics (IVD) Raw Materials Market Size, Share, & Trends Analysis Report by

  • Product: Antibody & Antigen, Enzymes, Proteins, Biological Buffers, and Others
  • Technology: Clinical Chemistry, Immunochemistry, Molecular Diagnostics, and Others
  • End-User: Pharma & Biotech Companies, Diagnostic Laboratories, and Others
  • Geography: Europe, North America, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

342 Pages

icon-table

164 Tables

icon-chart

139 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

39 Companies

icon-market

4 Market Segment

IVD RAW MATERIALS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 34.25 BILLION (2027)
CAGR (REVENUE) 5.86% (2022-2027)
BASE YEAR 2021
FORECAST PERIOD 2022-2027
MARKET SEGMENTS Product: Antibody & Antigen, Enzymes, Proteins, Biological Buffers, and Others, Technology: Clinical Chemistry, Immunochemistry, Molecular Diagnostics, and Others, End-User: Pharma & Biotech Companies, Diagnostic Laboratories, and Others, Geography: Europe, North America, APAC, Latin America, and Middle East & Africa
GEOGRAPHICAL ANALYSIS Europe, North America, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED Germany, Italy, France, UK, Spain, US, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa

MARKET OVERVIEW

IVD raw materials market size was valued at USD 24.34 billion in 2021 and is expected to reach USD 34.25 billion by 2027, growing at a CAGR of 5.86% during the forecast period.

With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share. It is expected to have the highest incremental growth of USD 3.92 billion and absolute growth of 44.41% during the forecast period.

The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased the speed and ease of using the devices the workforce is thoroughly trained and adopted. Furthermore, the global IVD raw materials market is expected to witness an incremental growth of USD 9.91 billion and absolute growth of 40.73% by 2027.

KEY HIGHLIGHTS

  • Growing trends for point of care diagnostics and personalized medicine contribute to the growth of the IVD raw materials market.
  • Investment in the development and commercial launch of IVD instruments and rapid test kits to diagnose several infectious diseases and their applications in the research segment will boost the market in developed countries.
  • In 2021, pharma & biotech companies accounted for the major share of 62.19% in the global IVD raw materials market. However, diagnostic laboratories are likely to witness the highest absolute growth of 43.37% during the forecast period.
  • Vendors offer a broad portfolio of quality enzymes that are highly suitable for manufacturing diagnostic kits and reagents. Manufacturers are also exploring new enzyme sources from enormous enzymes and optimizing and transforming the most appropriate enzyme molecules.

THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:

  • Product
  • Technology
  • End-User
  • Geography

SEGMENTATION ANALYSIS

Rapid tests developed through clinical chemistry provides test results immediately. Manufacturers offer many IVD raw materials applicable to clinical chemistry methods. The global IVD raw materials market by clinical chemistry is expected to reach USD 12.14 billion by 2027. Furthermore, private laboratories have expanded their footprints in recent years, especially in developing countries, which has stimulated market growth. Moreover, the demand for standalone reference laboratories is gradually rising due to the prevalence of epidemic and pandemic conditions across the globe. The global IVD raw materials market by diagnostic laboratories will grow at a CAGR of over 6% during 2022-2027.

COMPETITIVE LANDSCAPE

Major manufacturers of IVD raw materials are focusing on their proprietary processing techniques that satisfy the raw material requirements of the IVD industry and provide IVD raw materials made to their own with the off-the-shelf specification. Vendors are constantly investing resources in R&D projects based on market trends and the demand for general health management. Key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to enhance sales and profit margins. Strategic M&As continue to be an essential competitive strategy for key players to expand product offerings, access new technology, or increase market share. Vendors also focus on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the IVD raw materials market.

GEOGRAPHICAL ANALYSIS

In 2021, Europe dominated the global IVD raw materials market compared to other regions. This region is a mature market with developed diagnostic infrastructure available in most countries. The demand for advanced molecular diagnostics in the European countries has gone high owing to the presence of advanced infrastructure in healthcare diagnosis. Point of care diagnostics is the latest trend in the European market. The Europe IVD raw materials market is expected to reach USD 11.80 billion by 2027.

The report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

  • Segmentation Analysis by Product
    • Antibody & Antigen
    • Enzymes
    • Proteins
    • Biological Buffers
    • Others
  • Segmentation Analysis by Technology
    • Clinical Chemistry
    • Immunochemistry
    • Molecular Diagnostics
    • Others
  • Segmentation Analysis by End-User
    • Pharma & Biotech Companies
    • Diagnostic Laboratories
    • Others
  • Geography
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
    • North America
      • US
      • Canada
    • APAC
      • China
      • Japan
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • Turkey
      • Saudi Arabia
      • South Africa

Frequently Asked Questions

HOW BIG IS THE IVD RAW MATERIALS MARKET?

The IVD raw materials market to reach USD 34.25 billion by 2027.

WHAT ARE THE GROWTH ENABLERS IN THE IVD RAW MATERIALS MARKET?

Increasing prevalence of infectious & chronic diseases, growing awareness for early diagnosis and disease prevention, and surge in demand For IVD testing & devices are the growth enablers in the market.

WHO ARE THE KEY PLAYERS IN THE IVD RAW MATERIALS MARKET

Key players include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KGaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific.

WHICH REGION HOLDS THE LARGEST SHARE IN THE IVD RAW MATERIALS MARKET?

Europe holds the largest share in the IVD raw materials market.

WHAT ARE THE KEY TRENDS IN THE IVD RAW MATERIALS MARKET?

Rising demand for point of care PCR diagnostics, personalized medicine, and molecular diagnostics are the key trends in the IVD raw materials market.

Download Free Sample

The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027.

The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period:

  • Increasing Prevalence of Infectious & Chronic Diseases
  • Growing Awareness for Early Diagnosis and Disease Prevention
  • Surge In Demand for IVD Testing & Devices
  • Rise In Availability of Advanced Home Care Kits for Cancer Diagnostics

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the IVD raw materials market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

Key Vendors

  • Aalto Bio Reagents
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Fapon Biotech
  • Fujirebio
  • Merck KGaA
  • Hoffmann-La Roche
  • Thermo Fisher Scientific

Other Prominent Vendors

  • ABclonal
    • Business Overview
    • Product Offerings
  • BBI Solutions
  • Beijing Diagreat Biotechnology
  • Biofootprints Healthcare
  • BioPorto
  • Creative Diagnostics
  • CUSABIO Technology
  • EUPROTEIN
  • Eximio Biotec
  • GenScript ProBio
  • Getein Biotech
  • Glentham Life Sciences
  • HyTest 
  • ImmunoDiagnostics
  • LGC
  • Medix Biochemica
  • Meridian Bioscience
  • More Diagnostics
  • MP Biomedicals
  • Nanjing Okay Biotechnology
  • Nitto Boseki
  • OYC Europe
  • Prahas Healthcare
  • Promega
  • ReAgent
  • Rockland Immunochemicals
  • Sekisui Diagnostics
  • SERION Immunologics
  • Signalway Antibody
  • Suzhou Yacoo Science
  • Trina Bioreactives
  • Watson International
  • Wuhan Huamei Biotech

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY TECHNOLOGY

4.3.3 MARKET SEGMENTATION BY END USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS

8.2 SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE

8.3 RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS

8.4 ADVANCED TECHNOLOGIES IN IVD PRODUCTS

9 MARKET GROWTH ENABLERS

9.1 INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES

9.2 GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION

9.3 HIGH DEMAND FOR IVD TESTS & DEVICES

9.4 RISE IN AVAILABILITY OF ADVANCED HOME CARE KITS FOR CANCER DIAGNOSTICS

10 MARKET RESTRAINTS

10.1 LOT-TO-LOT VARIATIONS IN IVD REAGENTS

10.2 STRINGENT REGULATIONS FOR PRODUCT APPROVALS

10.3 LOWER PENETRATION OF IVD DEVICES IN LMICS

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 DEMAND FOR IVD RAW MATERIALS DURING COVID-19

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 ANTIBODIES & ANTIGENS

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION

12.4 ENZYMES

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 ENZYMES: GEOGRAPHY SEGMENTATION

12.5 PROTEINS

12.5.1 MARKET OVERVIEW

12.5.2 MARKET SIZE & FORECAST

12.5.3 PROTEINS: GEOGRAPHY SEGMENTATION

12.6 BIOLOGICAL BUFFERS

12.6.1 MARKET OVERVIEW

12.6.2 MARKET SIZE & FORECAST

12.6.3 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION

12.7 OTHERS

12.7.1 MARKET OVERVIEW

12.7.2 MARKET SIZE & FORECAST

12.7.3 OTHERS: GEOGRAPHY SEGMENTATION

13 TECHNOLOGY

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 CLINICAL CHEMISTRY

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION

13.4 IMMUNOCHEMISTRY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION

13.5 MOLECULAR DIAGNOSTICS

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION

13.6 OTHERS

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 OTHERS: GEOGRAPHY SEGMENTATION

14 END USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 PHARMA/BIOTECH & MEDTECH COMPANIES

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 PHARMA/BIOTECH & MEDTECH COMPANIES: GEOGRAPHY SEGMENTATION

14.4 DIAGNOSTIC LABORATORIES

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION

14.5 OTHERS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 OTHERS: GEOGRAPHY SEGMENTATION

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 GEOGRAPHIC OVERVIEW

16 EUROPE

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.2.1 EUROPE: PRODUCT

16.2.2 EUROPE: TECHNOLOGY

16.2.3 EUROPE: END USER

16.3 KEY COUNTRIES

16.3.1 GERMANY: MARKET SIZE & FORECAST

16.3.2 ITALY: MARKET SIZE & FORECAST

16.3.3 FRANCE: MARKET SIZE & FORECAST

16.3.4 UK: MARKET SIZE & FORECAST

16.3.5 SPAIN: MARKET SIZE & FORECAST

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.2.1 NORTH AMERICA: PRODUCT

17.2.2 NORTH AMERICA: TECHNOLOGY

17.2.3 NORTH AMERICA: END USER

17.3 KEY COUNTRIES

17.3.1 US: MARKET SIZE & FORECAST

17.3.2 CANADA: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.2.1 APAC: PRODUCT

18.2.2 APAC: TECHNOLOGY

18.2.3 APAC: END USER

18.3 KEY COUNTRIES

18.3.1 CHINA: MARKET SIZE & FORECAST

18.3.2 JAPAN: MARKET SIZE & FORECAST

18.3.3 INDIA: MARKET SIZE & FORECAST

18.3.4 AUSTRALIA: MARKET SIZE & FORECAST

18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.2.1 LATIN AMERICA: PRODUCT

19.2.2 LATIN AMERICA: TECHNOLOGY

19.2.3 LATIN AMERICA: END USER

19.3 KEY COUNTRIES

19.3.1 BRAZIL: MARKET SIZE & FORECAST

19.3.2 MEXICO: MARKET SIZE & FORECAST

19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.2.1 MIDDLE EAST & AFRICA: PRODUCT

20.2.2 MIDDLE EAST & AFRICA: TECHNOLOGY

20.2.3 MIDDLE EAST & AFRICA: END USER

20.3 KEY COUNTRIES

20.3.1 TURKEY: MARKET SIZE & FORECAST

20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST

20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

21.2.1 AALTO BIO REAGENTS

21.2.2 FAPON BIOTECH

21.2.3 FUJIREBIO

21.2.4 MERCK KGAA

21.2.5 F. HOFFMANN-LA ROCHE

21.2.6 THERMO FISHER SCIENTIFIC

22 KEY COMPANY PROFILES

22.1 AALTO BIO REAGENTS

22.1.1 BUSINESS OVERVIEW

22.1.2 AALTO BIO REAGENTS IN IVD RAW MATERIALS MARKET

22.1.3 PRODUCT OFFERINGS

22.1.4 KEY STRATEGIES

22.1.5 KEY STRENGTHS

22.1.6 KEY OPPORTUNITIES

22.2 FAPON BIOTECH

22.2.1 BUSINESS OVERVIEW

22.2.2 FAPON BIOTECH IN IVD RAW MATERIALS MARKET

22.2.3 PRODUCT OFFERINGS

22.2.4 KEY STRATEGIES

22.2.5 KEY STRENGTHS

22.2.6 KEY OPPORTUNITIES

22.3 FUJIREBIO

22.3.1 BUSINESS OVERVIEW

22.3.2 FUJIREBIO IN IVD RAW MATERIALS MARKET

22.3.3 PRODUCT OFFERINGS

22.3.4 KEY STRATEGIES

22.3.5 KEY STRENGTHS

22.3.6 KEY OPPORTUNITIES

22.4 MERCK KGAA

22.4.1 BUSINESS OVERVIEW

22.4.2 MERCK KGAA IN IVD RAW MATERIALS MARKET

22.4.3 PRODUCT OFFERINGS

22.4.4 KEY STRATEGIES

22.4.5 KEY STRENGTHS

22.4.6 KEY OPPORTUNITIES

22.5 F. HOFFMANN-LA ROCHE

22.5.1 BUSINESS OVERVIEW

22.5.2 F. HOFFMANN-LA ROCHE IN IVD RAW MATERIALS MARKET

22.5.3 PRODUCT OFFERINGS

22.5.4 KEY STRATEGIES

22.5.5 KEY STRENGTHS

22.5.6 KEY OPPORTUNITIES

22.6 THERMO FISHER SCIENTIFIC

22.6.1 BUSINESS OVERVIEW

22.6.2 THERMO FISHER SCIENTIFIC IN IVD RAW MATERIALS MARKET

22.6.3 PRODUCT OFFERINGS

22.6.4 KEY STRATEGIES

22.6.5 KEY STRENGTHS

22.6.6 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 ABCLONAL

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.2 BBI SOLUTIONS

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.3 BEIJING DIAGREAT BIOTECHNOLOGY

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.4 BIOFOOTPRINTS HEALTHCARE

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.5 BIOPORTO

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERINGS

23.6 CREATIVE DIAGNOSTICS

23.6.1 BUSINESS OVERVIEW

23.6.2 PRODUCT OFFERINGS

23.7 CUSABIO TECHNOLOGY

23.7.1 BUSINESS OVERVIEW

23.7.2 PRODUCT OFFERINGS

23.8 EUPROTEIN

23.8.1 BUSINESS OVERVIEW

23.8.2 PRODUCT OFFERINGS

23.9 EXIMIO BIOTEC

23.9.1 BUSINESS OVERVIEW

23.9.2 PRODUCT OFFERINGS

23.10 GENSCRIPT PROBIO

23.10.1 BUSINESS OVERVIEW

23.10.2 PRODUCT OFFERINGS

23.11 GETEIN BIOTECH

23.11.1 BUSINESS OVERVIEW

23.11.2 PRODUCT OFFERINGS

23.12 GLENTHAM LIFE SCIENCES

23.12.1 BUSINESS OVERVIEW

23.12.2 PRODUCT OFFERINGS

23.13 HYTEST

23.13.1 BUSINESS OVERVIEW

23.13.2 PRODUCT OFFERINGS

23.14 IMMUNODIAGNOSTICS

23.14.1 BUSINESS OVERVIEW

23.14.2 PRODUCT OFFERINGS

23.15 LGC

23.15.1 BUSINESS OVERVIEW

23.15.2 PRODUCT OFFERINGS

23.16 MEDIX BIOCHEMICA

23.16.1 BUSINESS OVERVIEW

23.16.2 PRODUCT OFFERINGS

23.17 MERIDIAN BIOSCIENCE

23.17.1 BUSINESS OVERVIEW

23.17.2 PRODUCT OFFERINGS

23.18 MORE DIAGNOSTICS

23.18.1 BUSINESS OVERVIEW

23.18.2 PRODUCT OFFERINGS

23.19 MP BIOMEDICALS

23.19.1 BUSINESS OVERVIEW

23.19.2 PRODUCT OFFERINGS

23.20 NANJING OKAY BIOTECHNOLOGY

23.20.1 BUSINESS OVERVIEW

23.20.2 PRODUCT OFFERINGS

23.21 NITTO BOSEKI

23.21.1 BUSINESS OVERVIEW

23.21.2 PRODUCT OFFERINGS

23.22 OYC EUROPE

23.22.1 BUSINESS OVERVIEW

23.22.2 PRODUCT OFFERINGS

23.23 PRAHAS HEALTHCARE

23.23.1 BUSINESS OVERVIEW

23.23.2 PRODUCT OFFERINGS

23.24 PROMEGA

23.24.1 BUSINESS OVERVIEW

23.24.2 PRODUCT OFFERINGS

23.25 REAGENT

23.25.1 BUSINESS OVERVIEW

23.25.2 PRODUCT OFFERINGS

23.26 ROCKLAND IMMUNOCHEMICALS

23.26.1 BUSINESS OVERVIEW

23.26.2 PRODUCT OFFERINGS

23.27 SEKISUI DIAGNOSTICS

23.27.1 BUSINESS OVERVIEW

23.27.2 PRODUCT OFFERINGS

23.28 SERION IMMUNOLOGICS

23.28.1 BUSINESS OVERVIEW

23.28.2 PRODUCT OFFERINGS

23.29 SIGNALWAY ANTIBODY

23.29.1 BUSINESS OVERVIEW

23.29.2 PRODUCT OFFERINGS

23.30 SUZHOU YACOO SCIENCE

23.30.1 BUSINESS OVERVIEW

23.30.2 PRODUCT OFFERINGS

23.31 TRINA BIOREACTIVES

23.31.1 BUSINESS OVERVIEW

23.31.2 PRODUCT OFFERINGS

23.32 WATSON INTERNATIONAL

23.32.1 BUSINESS OVERVIEW

23.32.2 PRODUCT OFFERINGS

23.33 WUHAN HUAMEI BIOTECH

23.33.1 BUSINESS OVERVIEW

23.33.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS

24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 MARKET BY PRODUCT

25.1.1 EUROPE: PRODUCT SEGMENTATION

25.1.2 NORTH AMERICA: PRODUCT SEGMENTATION

25.1.3 APAC: PRODUCT SEGMENTATION

25.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

25.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

25.2 MARKET BY TECHNOLOGY

25.2.1 EUROPE: TECHNOLOGY SEGMENTATION

25.2.2 NORTH AMERICA: TECHNOLOGY SEGMENTATION

25.2.3 APAC: TECHNOLOGY SEGMENTATION

25.2.4 LATIN AMERICA: TECHNOLOGY SEGMENTATION

25.2.5 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION

25.3 MARKET BY END USER

25.3.1 EUROPE: END USER SEGMENTATION

25.3.2 NORTH AMERICA: END-USER SEGMENTATION

25.3.3 APAC: END-USER SEGMENTATION

25.3.4 LATIN AMERICA: END-USER SEGMENTATION

25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

25.4 MARKET BY GEOGRAPHY

25.4.1 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION

25.4.2 ENZYMES: GEOGRAPHY SEGMENTATION

25.4.3 PROTEINS: GEOGRAPHY SEGMENTATION

25.4.4 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION

25.4.5 OTHER PRODUCTS: GEOGRAPHY SEGMENTATION

25.4.6 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION

25.4.7 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION

25.4.8 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION

25.4.9 OTHER TECHNOLOGIES: GEOGRAPHY SEGMENTATION

25.4.10 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION

25.4.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION

25.4.12 OTHER END USERS: GEOGRAPHY SEGMENTATION

26 APPENDIX

26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL IVD RAW MATERIALS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 IMPACT OF GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS

EXHIBIT 4 IMPACT OF SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE

EXHIBIT 5 IMPACT OF RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS

EXHIBIT 6 IMPACT OF ADVANCED TECHNOLOGIES IN IVD PRODUCTS

EXHIBIT 7 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES

EXHIBIT 8 IMPACT OF GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION

EXHIBIT 9 MAJOR ADVANTAGES OF EARLY DIAGNOSIS AND DISEASE PREVENTION

EXHIBIT 10 IMPACT OF HIGH DEMAND FOR IVD TESTS & DEVICES

EXHIBIT 11 IMPACT OF RISE IN AVAILABILITY OF ADVANCED HOMECARE KITS FOR CANCER DIAGNOSTICS

EXHIBIT 12 IMPACT OF LOT-TO-LOT VARIATIONS IN IVD REAGENTS

EXHIBIT 13 IMPACT OF STRINGENT REGULATIONS FOR PRODUCT APPROVALS

EXHIBIT 14 IMPACT OF LOWER PENETRATION OF IVD DEVICES IN LMICS

EXHIBIT 15 GLOBAL IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 16 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT

EXHIBIT 17 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY

EXHIBIT 18 GLOBAL IVD RAW MATERIALS MARKET BY END USER

EXHIBIT 19 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY

EXHIBIT 20 WEEKLY MOLECULAR ASSAYS PERFORMED IN US AND EUROPE DURING NOVEMBER 2020 (MILLIONS)

EXHIBIT 21 FIVE FORCES ANALYSIS 2021

EXHIBIT 22 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 23 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT

EXHIBIT 24 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 25 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 26 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 27 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 ($ BILLION)

EXHIBIT 28 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 29 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 30 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 ($ BILLION)

EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 32 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 ($ BILLION)

EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 35 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 36 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 ($ BILLION)

EXHIBIT 37 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 38 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION)

EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 41 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 42 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY

EXHIBIT 43 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH

EXHIBIT 44 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH

EXHIBIT 45 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 46 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION)

EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 48 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION)

EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 51 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 ($ BILLION)

EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 58 GLOBAL IVD RAW MATERIALS MARKET BY END USER

EXHIBIT 59 GLOBAL IVD RAW MATERIALS MARKET BY END USER: INCREMENTAL GROWTH

EXHIBIT 60 GLOBAL IVD RAW MATERIALS MARKET BY END USER: ABSOLUTE GROWTH

EXHIBIT 61 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION)

EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 64 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 65 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION)

EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 67 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION)

EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 70 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 71 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY

EXHIBIT 72 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)

EXHIBIT 73 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 74 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 75 EUROPE IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)

EXHIBIT 76 EUROPE IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 77 EUROPE IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 78 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 80 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 81 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 82 GERMANY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 83 ITALY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 84 FRANCE IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 85 UK IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 86 SPAIN IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 87 NORTH AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)

EXHIBIT 88 NORTH AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 89 NORTH AMERICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 90 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 91 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 92 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 93 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 94 US IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 95 CANADA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 96 APAC IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)

EXHIBIT 97 APAC IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 98 APAC IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 99 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 100 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 101 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 102 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 103 CHINA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 104 JAPAN IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 105 INDIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 106 AUSTRALIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 107 SOUTH KOREA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 108 LATIN AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)

EXHIBIT 109 LATIN AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 110 LATIN AMERICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 111 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 112 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 113 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 115 BRAZIL IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 116 MEXICO IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 117 ARGENTINA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 118 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)

EXHIBIT 119 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 120 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 121 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 122 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 123 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 124 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 125 TURKEY IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 126 SAUDI ARABIA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 127 SOUTH AFRICA IVD RAW MATERIALS MARKET 2021–2027 ($ BILLION)

EXHIBIT 128 MERCK KGAA: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 129 MERCK KGAA: REVENUE BREAKDOWN BY SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 130 MERCK KGAA: R&D EXPENDITURE 2018–2020 ($ MILLION)

EXHIBIT 131 MERCK KGAA: REVENUE BY GEOGRAPHIC REGION 2018–2020 ($ MILLION)

EXHIBIT 132 F. HOFFMANN-LA ROCHE: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 133 F. HOFFMANN-LA ROCHE: REVENUE BREAKDOWN BY DIVISION 2019–2021 ($ MILLION)

EXHIBIT 134 F. HOFFMANN-LA ROCHE: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 135 F. HOFFMANN-LA ROCHE: REVENUE BY GEOGRAPHICAL REGION 2019–2021 ($ MILLION)

EXHIBIT 136 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 137 THERMO FISHER SCIENTIFIC: REVENUE BREAKDOWN BY SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 138 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2018–2020 ($ MILLION)

EXHIBIT 139 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHICAL REGION 2018–2020 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015–2021

TABLE 3 LIST OF SOME IVD RAW MATERIALS APPLICABLE FOR DIFFERENT FUNCTIONS AND SYSTEMS

TABLE 4 VENDORS OFFERING ANTIBODIES & ANTIGENS AS IVD RAW MATERIALS

TABLE 5 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 6 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021–2027 (%) (GEOGRAPHY)

TABLE 7 VENDORS OFFERING ENZYMES AS IVD RAW MATERIALS

TABLE 8 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 9 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021–2027 (%) (GEOGRAPHY)

TABLE 10 VENDORS OFFERING PROTEINS AS IVD RAW MATERIALS

TABLE 11 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 12 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021–2027 (%) (GEOGRAPHY)

TABLE 13 VENDORS OFFERING BIOLOGICAL BUFFERS AS IVD RAW MATERIALS

TABLE 14 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 15 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 (%) (GEOGRAPHY)

TABLE 16 VENDORS OFFERING HORMONES AS IVD RAW MATERIALS

TABLE 17 VENDORS OFFERING OTHER IVD RAW MATERIALS

TABLE 18 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 19 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 (%) (GEOGRAPHY)

TABLE 20 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 21 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 (%) (GEOGRAPHY)

TABLE 22 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 23 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 (%) (GEOGRAPHY)

TABLE 24 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 25 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 (%) (GEOGRAPHY)

TABLE 26 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 27 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021–2027 (%) (GEOGRAPHY)

TABLE 28 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 29 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 (%) (GEOGRAPHY)

TABLE 30 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 31 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 (%) (GEOGRAPHY)

TABLE 32 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 33 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 (%) (GEOGRAPHY)

TABLE 34 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 35 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 36 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 37 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 38 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 39 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 40 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 41 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 42 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 43 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 44 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 45 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 46 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 47 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 48 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 49 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 50 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 51 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 52 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 53 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 54 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 55 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 56 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 57 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 58 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 59 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 60 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 61 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 62 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 63 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 64 AALTO BIO REAGENTS: MAJOR PRODUCT OFFERINGS

TABLE 65 FAPON BIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 66 FUJIREBIO: MAJOR PRODUCT OFFERINGS

TABLE 67 MERCK KGAA: MAJOR PRODUCT OFFERINGS

TABLE 68 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS

TABLE 69 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 70 ABCLONAL: MAJOR PRODUCT OFFERINGS

TABLE 71 BBI SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 72 BEIJING DIAGREAT BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 73 BIOFOOTPRINTS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 74 BIOPORTO: MAJOR PRODUCT OFFERINGS

TABLE 75 CREATIVE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 76 CUSABIO TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 77 EUPROTEIN: MAJOR PRODUCT OFFERINGS

TABLE 78 EXIMIO BIOTEC: MAJOR PRODUCT OFFERINGS

TABLE 79 GENSCRIPT PROBIO: MAJOR PRODUCT OFFERINGS

TABLE 80 GETEIN BIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 81 GLENTHAM LIFE SCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 82 HYTEST: MAJOR PRODUCT OFFERINGS

TABLE 83 IMMUNODIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 84 LGC: MAJOR PRODUCT OFFERINGS

TABLE 85 MEDIX BIOCHEMICA: MAJOR PRODUCT OFFERINGS

TABLE 86 MERIDIAN BIOSCIENCE: MAJOR PRODUCT OFFERINGS

TABLE 87 MORE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 88 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS

TABLE 89 NANJING OKAY BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 90 NITTO BOSEKI: MAJOR PRODUCT OFFERINGS

TABLE 91 OYC EUROPE: MAJOR PRODUCT OFFERINGS

TABLE 92 PRAHAS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 93 PROMEGA: MAJOR PRODUCT OFFERINGS

TABLE 94 REAGENT: MAJOR PRODUCT OFFERINGS

TABLE 95 ROCKLAND IMMUNOCHEMICALS: MAJOR PRODUCT OFFERINGS

TABLE 96 SEKISUI DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 97 SERION IMMUNOLOGICS: MAJOR PRODUCT OFFERINGS

TABLE 98 SIGNALWAY ANTIBODY: MAJOR PRODUCT OFFERINGS

TABLE 99 SUZHOU YACOO SCIENCE: MAJOR PRODUCT OFFERINGS

TABLE 100 TRINA BIOREACTIVES: MAJOR PRODUCT OFFERINGS

TABLE 101 WATSON INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 102 WUHAN HUAMEI BIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 103 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 104 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 105 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 106 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 107 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 108 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 109 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 110 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 111 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 112 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 113 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 ($ BILLION)

TABLE 114 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021–2027 (%)

TABLE 115 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 116 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 117 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 118 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 119 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 120 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 121 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 122 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 123 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 124 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 125 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)

TABLE 126 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021–2027 (%)

TABLE 127 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 128 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 129 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 130 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 131 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 132 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 133 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 134 APAC IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 135 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 136 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 137 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 138 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021–2027 (%)

TABLE 139 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 140 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 141 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 142 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021–2027 (%)

TABLE 143 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 144 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021–2027 (%)

TABLE 145 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 146 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021–2027 (%)

TABLE 147 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 148 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021–2027 (%) (GEOGRAPHY)

TABLE 149 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 150 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021–2027 (%) (GEOGRAPHY)

TABLE 151 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 152 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021–2027 (%) (GEOGRAPHY)

TABLE 153 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 154 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021–2027 (%) (GEOGRAPHY)

TABLE 155 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 156 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021–2027 (%) (GEOGRAPHY)

TABLE 157 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 158 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021–2027 (%) (GEOGRAPHY)

TABLE 159 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 160 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 (%) (GEOGRAPHY)

TABLE 161 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 162 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021–2027 (%) (GEOGRAPHY)

TABLE 163 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 ($ BILLION) (GEOGRAPHY)

TABLE 164 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021–2027 (%) (GEOGRAPHY)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date